Brief: Tela Bio Q2 Revenue Rose 38 Percent To $10.4 Million
10/08/2022 21:58
TELA Bio Inc TELA.O :
* TELA BIO REPORTS SECOND QUARTER 2022 FINANCIAL RESULTS
* SEES FY REVENUE $42 MILLION TO $45 MILLION
* Q2 REVENUE ROSE 38 PERCENT TO $10.4 MILLION
* CASH AND CASH EQUIVALENTS ON JUNE 30, 2022, TOTALED $27.7
MILLION
* QTRLY NET LOSS PER COMMON SHARE, BASIC AND DILUTED $0.88
Source text for Eikon: ID:nGNX29hqxc
Further company coverage: TELA.O
Recent news on TELA Bio
See all newsBrief: Tela Bio - Receives FDA 510(K) Clearance For Liora Monofilament Scaffold For Soft Tissue Reinforcement
Tela Bio Inc Reports Results For The Quarter Ended June 30: Earnings Summary
TELA Bio Q2 revenue falls on lower OviTex PRS volumes, withdraws outlook
Brief: TELA Bio Q2 Revenue USD 19.291 Million Vs. IBES Estimate USD 20 Million
Tela Bio Inc Expected To Post A Loss Of 18 Cents A Share: Earnings Preview